PubRank

Christian Mottet

Author PubWeight™ 34.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J Immunol 2006 4.04
2 The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis 2009 3.66
3 In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance. Blood 2006 2.28
4 Control of immune pathology by regulatory T cells. Novartis Found Symp 2003 1.79
5 Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease. Inflamm Bowel Dis 2011 1.41
6 Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol 2008 1.01
7 Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss Med Wkly 2007 0.97
8 When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel. J Crohns Colitis 2013 0.96
9 Extraintestinal manifestations of Crohn's disease. Digestion 2008 0.93
10 First-line therapies in inflammatory bowel disease. Digestion 2012 0.91
11 Fibrostenotic Crohn's disease. Digestion 2008 0.88
12 Extraintestinal manifestations of Crohn's disease. Digestion 2005 0.85
13 Report of the ECCO workshop on anti-TNF therapy failures in inflammatory bowel diseases: biological roles and effects of TNF and TNF antagonists. J Crohns Colitis 2010 0.85
14 Obstructive fibrostenotic Crohn's disease. Digestion 2005 0.85
15 Patients' information-seeking activity is associated with treatment compliance in inflammatory bowel disease patients. Scand J Gastroenterol 2014 0.84
16 Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approach. Digestion 2007 0.82
17 Characteristics of non-responders to self-reported questionnaires in a large inflammatory bowel disease cohort study. Scand J Gastroenterol 2015 0.81
18 Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II. J Crohns Colitis 2009 0.81
19 Treatment of postoperative Crohn's disease. Digestion 2005 0.80
20 Treatment of fibrostenotic and fistulizing Crohn's disease. Digestion 2012 0.80
21 Appropriateness of therapy for active Crohn's disease: Results of a multidisciplinary international expert panel-EPACT II. J Crohns Colitis 2009 0.80
22 Drug safety in Crohn's disease therapy. Digestion 2008 0.79
23 Severe and steroid-resistant Crohn's disease. Digestion 2008 0.79
24 Prevalence of Inflammatory Bowel Disease in the Canton of Vaud (Switzerland): A population-based cohort study. J Crohns Colitis 2007 0.79
25 Severe and steroid-resistant Crohn's disease. Digestion 2005 0.79
26 Penetrating or stricturing diseases are the major determinants of time to first and repeat resection surgery in Crohn's disease. Digestion 2013 0.79
27 Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness. Eur J Gastroenterol Hepatol 2010 0.79
28 Fistulizing Crohn's disease. Digestion 2008 0.78
29 Appropriateness of early management of newly diagnosed Crohn's disease in a European population-based cohort. Scand J Gastroenterol 2010 0.78
30 Maintenance of surgically induced remission of Crohn's disease. Digestion 2008 0.77
31 Homing of intestinal immune cells. Novartis Found Symp 2004 0.76
32 Maintenance of remission in Crohn's disease. Digestion 2005 0.76
33 Acceptance of inflammatory bowel disease treatment recommendations based on appropriateness ratings: do practicing gastroenterologists agree with experts? J Crohns Colitis 2015 0.75
34 [Intestinal inflammatory diseases]. Rev Med Suisse 2007 0.75
35 Maintenance of medically induced remission of Crohn's disease. Digestion 2008 0.75
36 Fistulizing Crohn's disease. Digestion 2005 0.75
37 Mild-to-moderate active luminal Crohn's disease. Digestion 2008 0.75
38 Appropriate maintenance treatment for Crohn's disease: Results of a multidisciplinary international expert panel - EPACT II. J Crohns Colitis 2009 0.75
39 Drug safety in the treatment of Crohn's disease. Digestion 2005 0.75
40 Therapy of mild to moderate luminal Crohn's disease. Digestion 2005 0.75
41 [Main therapeutic advances in IBD in 2007]. Rev Med Suisse 2008 0.75
42 EPACT II: project and methods. Digestion 2008 0.75